BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12593941)

  • 1. Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex.
    Valero M; Pérez-Revuelta BI; Rodríguez LJ
    Int J Pharm; 2003 Mar; 253(1-2):97-110. PubMed ID: 12593941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary naproxen: beta-cyclodextrin:polyethylene glycol complex formation.
    Valero M; Carrillo C; Rodríguez LJ
    Int J Pharm; 2003 Oct; 265(1-2):141-9. PubMed ID: 14522127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT; Mura P
    Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of binary and ternary polyvinylpyrrolidone and/or hydroxypropyl-beta-cyclodextrin complexes on the photochemical and photosensitizing properties of Naproxen.
    Valero M; Esteban B
    J Photochem Photobiol B; 2004 Oct; 76(1-3):95-102. PubMed ID: 15488720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers.
    Mura P; Faucci MT; Maestrelli F; Furlanetto S; Pinzauti S
    J Pharm Biomed Anal; 2002 Aug; 29(6):1015-24. PubMed ID: 12110386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.
    Mura P; Maestrelli F; Cirri M
    Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin based ternary system of modafinil: Effect of trimethyl chitosan and polyvinylpyrrolidone as complexing agents.
    Patel P; Agrawal YK; Sarvaiya J
    Int J Biol Macromol; 2016 Mar; 84():182-8. PubMed ID: 26697780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
    Smith JS; Macrae RJ; Snowden MJ
    Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state.
    Bettinetti G; Mura P; Faucci MT; Sorrenti M; Setti M
    Eur J Pharm Sci; 2002 Feb; 15(1):21-9. PubMed ID: 11803128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
    Li J; Xiao H; Li J; Zhong Y
    Int J Pharm; 2004 Jul; 278(2):329-42. PubMed ID: 15196638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A; Nies E; Van den Mooter G
    Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anti-inflammatory properties for naproxen with cyclodextrin-grafted polysaccharides.
    Ramírez HL; Cao R; Fragoso A; Torres-Labandeira JJ; Dominguez A; Schacht EH; Baños M; Villalonga R
    Macromol Biosci; 2006 Jul; 6(7):555-61. PubMed ID: 16921542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
    Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
    Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution.
    Bettinetti G; Melani F; Mura P; Monnanni R; Giordano F
    J Pharm Sci; 1991 Dec; 80(12):1162-70. PubMed ID: 1815076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QbD Assisted Systematic Review for Optimizing the Selection of PVP as a Ternary Substance in Enhancing the Complexation Efficiency of Cyclodextrins: a Pilot Study.
    Mulenga G; Alahmed TAA; Sami F; Majeed S; Ali MS; Le JLJ; Rhu CLQ; Nair RS; Hasan N; Ansari MT
    AAPS PharmSciTech; 2024 Jun; 25(5):134. PubMed ID: 38862663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen bonding in a non-steroidal anti-inflammatory drug--Naproxen.
    Velazquez MM; Valero M; Rodríguez LJ; Costa SM; Santos MA
    J Photochem Photobiol B; 1995 Jul; 29(1):23-31. PubMed ID: 7472800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.